How effective is mitotane? Can long-term treatment improve prognosis?

Mitotane (Mitotane) is a drug commonly used to treat adrenocortical cancer (ACC) and has significant therapeutic effects. It achieves the purpose of treating cancer by inhibiting the function of adrenocortical cells and reducing the growth and proliferation of tumor cells. Mitotane is often used as adjuvant therapy after surgery or as primary treatment when surgery is not possible or disease has recurred.

Mitotane has been extensively studied for its effectiveness in the treatment of adrenocortical cancer. For people with early-stage adrenocortical cancer, mitotane is often given in combination with other treatments, such as surgery or radiation therapy, to help reduce the risk of the cancer coming back. For patients with advanced or metastatic adrenocortical cancer, mitotane can be used as a monotherapy or in combination with chemotherapy drugs to help slow tumor progression. Mitotane can effectively control the progression of the disease, reduce tumor growth, and prolong the survival of patients.

The effect of long-term use of mitotane is relatively significant. For some patients, long-term use of mitotane can effectively control the disease and delay tumor progression, thereby improving the patient's survival and quality of life. Studies have shown that a significant number of patients who receive long-term treatment with mitotane are able to maintain stable disease or even achieve partial remission. However, since mitotane may cause certain side effects, such as liver damage, digestive system discomfort, etc., careful monitoring is required during long-term use.

Although mitotane has good efficacy in the treatment of adrenocortical cancer, its side effects cannot be ignored. Common side effects include abnormal liver function, nausea, vomiting, fatigue, etc. Long-term use requires regular monitoring of liver function and other related indicators. Doctors will adjust the treatment plan according to the patient's specific response to ensure the safety of the treatment.

Mitotane has significant efficacy in the treatment of adrenocortical cancer, especially playing an important role in adjuvant therapy and advanced tumor treatment. With long-term use, mitotane can help improve patient prognosis and extend survival. However, patients need to be closely monitored for side effects while taking mitotane to ensure the treatment is safe and effective.

Reference materials:https://go.drugbank.com/drugs/DB00648